Eswar Iyer is the CEO and Co-founder of Aikium, a biotech company pioneering AI-driven synthetic biology to unlock the undruggable proteome.
Under his leadership, Aikium has developed Yotta-ML²—the first AI-powered platform capable of screening a trillion proteins. Combining generative AI with large-protein display technology, Yotta-ML² enables Yotta-scale machine learning to tackle diseases once considered out of reach.
This work builds on Eswar’s deep background in AI, multiomics, and protein engineering. He holds 100+ patents and helped launch spatial biology platforms like Xenium and Visium-HD during his time at 10x Genomics. At Harvard and the Wyss Institute, he led foundational work in transcriptomics, CRISPR screening, and tissue engineering.
